Calvin Chin
SelectiveNamed in filings at E14 FundOn the current fund
- Board seats filed
- 6
all filings on record
Named in filings at E14 FundOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Netpreme | Developer tools & infrastructure | June 2025 | Boldstart Ventures |
| Fieldstone Bio | Biotech & pharma | December 2024 | None on file |
| Maniro | Not yet classified | August 2024 | None on file |
| Brelyon | Robotics & hardware | May 2022 | None on file |
| Sourcemap | Enterprise software | February 2022 | Energize Ventures |
| DxLab | Medical devices | December 2020 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Calvin Chin on the board, based on 5 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.